PPARG and sarcoidosis: Moreover, PPARγ antagonist treatment of wild-type mice elevated T cell mediator production [21] suggesting that persistent PPARγ deficiency such as noted in sarcoidosis alveolar macrophages [20] may help to maintain an elevated Th1 cell profile.